Cargando…
Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibiting moderate effect on normal stem cells growth
Glioblastomas (GBM), also known as glioblastoma multiforme, are the most aggressive type of brain cancers. Currently, there is no real treatment for GBM and thus there is a compelling need for new therapeutic strategies for such type of cancers. Recently, we demonstrated that specific combinations o...
Autores principales: | Alexanian, Arshak, Stoellinger, Heidi, De Araujo Farias, Virginea, Quinones-Hinojosa, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055614/ https://www.ncbi.nlm.nih.gov/pubmed/36993520 http://dx.doi.org/10.21203/rs.3.rs-2698139/v1 |
Ejemplares similares
-
Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma
por: Gupta, Kshama, et al.
Publicado: (2022) -
Dopaminergic-like cells from epigenetically reprogrammed mesenchymal stem cells
por: Zhang, Zhiying, et al.
Publicado: (2012) -
Viability fingerprint of glioblastoma cell lines: roles of mitotic, proliferative, and epigenetic targets
por: Lavogina, Darja, et al.
Publicado: (2021) -
Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151()()
por: Tilghman, Jessica, et al.
Publicado: (2016) -
Filtered circular fingerprints improve either prediction or runtime performance while retaining interpretability
por: Gütlein, Martin, et al.
Publicado: (2016)